Vasomotor Symptoms Clinical Trials

66 clinical trials for Vasomotor Symptoms across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy — RECRUITING · PHASE2
• Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY) — RECRUITING
• Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture — RECRUITING · NA
• Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause — RECRUITING · NA
• Impact of Lean Pork on Endothelial Function in Perimenopause — RECRUITING · NA
• JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women — RECRUITING · NA
• Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). — RECRUITING · PHASE2
• A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF FEZOLINETANT FOR TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS (HOT FLASHES) IN WOMEN WITH STAGE 0 TO 3 HORMONE RECEPTOR-POSITIVE BREAST CANCER WHO ARE RECEIVING ADJUVANT ENDOCRINE THERAPY — RECRUITING · PHASE3
• A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ELINZANETANT FOR THE TREATMENT OF VASOMOTOR SYMPTOMS CAUSED BY ADJUVANT ENDOCRINE THERAPY, OVER 52 WEEKS AND OPTIONALLY FOR ADDITIONAL UP TO 3.5 YEARS IN WOMEN WITH, OR AT HIGH RISK FOR DEVELOPING HORMONE-RECEPTOR POSITIVE BREAST CANCER — RECRUITING
• THE EFFECT OF CONJUGATED ESTROGENS/ BAZEDOXIFENE (CE/ BZA) ON PERI- AND POSTMENOPAUSAL MOOD AND ANXIETY SYMPTOMS: A PILOT STUDY. — RECRUITING
• A double-blind, randomized, placebo and active controlled, multicenter study to investigate efficacy and safety after oral administration of 2 and 3 mg ZK 283197, 1 mg 17ß-estradiol and placebo once daily for 8 weeks in postmenopausal women with hot flushes — COMPLETED · PHASE2
• Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition — NOT_YET_RECRUITING · PHASE4
• Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes — NOT_YET_RECRUITING · NA
• Waning Moon: A Whole Person Health Intervention Designed by and for Urban Menopausal American Indian/Alaska Native Women — NOT_YET_RECRUITING · NA
• Goji Berry and Vasomotor Symptoms Pilot Study — NOT_YET_RECRUITING · NA
• A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT) — NOT_YET_RECRUITING · PHASE2
• Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong — ACTIVE_NOT_RECRUITING · NA
• Vasomotor Symptoms in Post-Hysterectomy Women With Ovarian Conservation — COMPLETED
• Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women — COMPLETED · NA
• A Study to Investigate Relative Bioavailability, Safety and Tolerability of Single- and Multiple-doses of Elinzanetant in Healthy Female Participants — COMPLETED · PHASE1
• Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms — COMPLETED · PHASE2
• Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II) — COMPLETED · PHASE3
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of MT-8554 in Female Subjects Experiencing Vasomotor Symptoms — COMPLETED · PHASE1
• Stellate Ganglion Blockade in Post-Menopausal Women — WITHDRAWN · PHASE2
• A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers — COMPLETED · PHASE1
• Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) — COMPLETED · PHASE3
• Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women — COMPLETED · PHASE1
• A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause — COMPLETED · PHASE3
• A Survey About Hot Flashes in Women Going Through the Menopause — COMPLETED
• A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women — COMPLETED · PHASE1
• Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women — COMPLETED · NA
• A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women — OTHER · PHASE2
• Study of HS-10384 in Participants of Chinese Postmenopausal Women — OTHER · PHASE1
• FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms — COMPLETED · PHASE2
• HIRREM Hot Flashes Study — COMPLETED · NA
• Determination of the Effects of Autogenic Relaxation Exercise and Cold Pillow Application on Vasomotor Symptom Control and Quality of Life in Postmenopausal Women — COMPLETED · NA
• Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms — OTHER · PHASE3
• Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer — TERMINATED · PHASE2
• Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor — COMPLETED · PHASE2
• The Effect of Health Education and Progressive Muscle Relaxation Exercise on Vasomotor Symptoms and Sleep Problems With Perimenopausal Women — COMPLETED · NA
• Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen — COMPLETED · PHASE1
• Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) — COMPLETED · PHASE3
• Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/MK-8265-012) — COMPLETED · PHASE3
• Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms — TERMINATED · PHASE2
• Effect of Yoga on Objective and Subjective Menopausal Hot Flashes — COMPLETED · NA
• Acupuncture in Menopause — COMPLETED · NA
• Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients — TERMINATED
• Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS) — TERMINATED · PHASE2
• Vasomotor Symptoms and Cardiovascular Control — WITHDRAWN · NA
• PLACEBO-CONTROLLED, DOUBLE-BLIND, PROSPECTIVE AND RANDOMIZED PHASE III STUDY TO EVALUATE THE EFFECT OF 12-WEEK TREATMENT WITH DHEA (PRASTERONE) + LOW DOSE ACOLBIFENE ON VASOMOTOR SYMPTOMS (HOT FLUSHES) IN POSTMENOPAUSAL WOMEN — NOT_YET_RECRUITING · PHASE3

Refine this search